FDA DEVICE FACTS
HERA Interlocking Intramedullary Nailing System
ZheJiang Decans Medical Devices Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Femoral Trochanteric Fixation Nail System: Intended for pertrochanteric, intertrochanteric, or subtrochanteric fractures; combination fractures of the femur; pathological fractures or reconstruction following tumor resection and grafting; poor healing of fractures, including nonunions, malunions, and bone lengthening or shortening; and other femoral fractures, including simple, severely comminuted, spiral, long-oblique, and segmental fractures. Antegrade Femoral Reconstruction Nail System: Reconstruction mode is intended for femoral-shaft and femoral-neck fractures; standard mode is intended for femoral-shaft fractures. Tibial Nail System: Intended for implantation into the medullary canal of the tibia for alignment, stabilization, and fixation of fractures caused by trauma or disease.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。